Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links (Q34481838)

2 August 2017

1 reference

title

Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links (English)

1 reference

2 August 2017

Vasan S

1

1 reference

2 August 2017

Foiles PG

series ordinal

2

1 reference

2 August 2017

Founds HW

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

1977-1987

1 reference

2 August 2017

11

1 reference

Lilly Lecture 1993. Glycation and diabetic complications

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Glycation products and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycosylation end products in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycation end products: a Nephrologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Cerebroprotective effects of aminoguanidine in a rodent model of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Glucose: a continuous risk factor for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycation end-products and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Biological effects of aminoguanidine: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Renoprotective effects of a novel inhibitor of advanced glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Novel inhibitors of advanced glycation endproducts (part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1977

10.1517/13543784.10.11.1977

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference